Status:
RECRUITING
Cutaneous Hydration Assessment in SCD
Lead Sponsor:
Enrico Novelli
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
12+ years
Phase:
NA
Brief Summary
This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration statu...
Detailed Description
Vaso-occlusive episodes (VOE) are the leading cause of hospitalization for patients with SCD. Intravenous fluid replacement is one of the cornerstones of management of VOE in the emergency department ...
Eligibility Criteria
Inclusion
- Diagnosis of Sickle Cell Disease (genotypes SS, SC, Sß-thalassemia, SD, SOArab)
- Participants must be ≥12-years old
- Participants that provide legally effective consent to all study procedures
Exclusion
- Participants under 12-years old
- Participants being treated with experimental therapies in clinical trials
Key Trial Info
Start Date :
January 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05210114
Start Date
January 21 2022
End Date
December 31 2027
Last Update
November 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPMC Sickle Cell Clinic
Pittsburgh, Pennsylvania, United States, 15213